Shanghai Henlius Biotech announced that the FDA has granted Orphan Drug Designation for HLX22, an anti-HER2 monoclonal ...

Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximately ...

"I wanted to create a bottle that enables you to easily store, transport, and dispense pre/post-workout mixes and pills at the gym or during a workout," said an inventor, from Valrico, Fla., "so I ...

LUND, SE / ACCESS Newswire / March 20, 2025 /Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that the U.S. Food ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...

Vici Energy, an integrated energy company, announced today the opening of its new Renovo Energy (Renovo) trading desk in ...

StoneFly, Inc. (iscsi.com) a leader in storage, HCI, backup and disaster recovery, cloud, and AI storage solutions, has announced a significant update to its DR365V appliance, integrating a Secure ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard care in this patient population. Perioperative treatment with durvalumab ...

On February 23, 2025, Celltrion announced that the European Commission (“EC”) approved its tocilizumab biosimilar, AVTOZMA® (CT-P47), referencing Roche’s ROACTEMRA®. Tocilizumab is a ...